6/5/2015 12:28:09 PM - Proposed a new Public Offering on 6/03/15. Currently consolidating below is 50 DMA line. Reported earnings +56% on +52% sales revenues for the Mar '15 quarter, but fundamental concerns remain. Prior quarterly comparisons have not been strong and steady above the +25% minimum guideline (C criteria).
2/28/2014 12:20:42 PM - Small gap down today, retreating from its 52-week high. Reported earnings -39% on -22% sales revenues for the Dec '13 quarter. Prior mid-day reports cautioned members - "Reported earnings +5% on -5% sales revenues for the Sep '13 quarter. Prior quarterly comparisons have not been strong and steady above the +25% minimum guideline (C criteria). It survived but failed to impress since noted near its all-time high in the 4/11/11 mid-day report with caution. - 'Gapped up today for a new high after announcing plans to buy American Medical Systems Holdings Inc. (AMMD) in a near $3 Billion deal. It was already extended from a sound base as noted after 3/30/11 when it technically broke out of a long flat base while merger news involving Cephalon Inc (CEPH) after Valeant Pharmaceuticals Int'l (VRX) sparked bullish action in the industry.'"
2/27/2014 12:27:10 PM - Hitting yet another new 52-week high today. Prior mid-day reports cautioned members - "Reported earnings +5% on -5% sales revenues for the Sep '13 quarter. Prior quarterly comparisons have not been strong and steady above the +25% minimum guideline (C criteria). It survived but failed to impress since noted near its all-time high in the 4/11/11 mid-day report with caution. - 'Gapped up today for a new high after announcing plans to buy American Medical Systems Holdings Inc. (AMMD) in a near $3 Billion deal. It was already extended from a sound base as noted after 3/30/11 when it technically broke out of a long flat base while merger news involving Cephalon Inc (CEPH) after Valeant Pharmaceuticals Int'l (VRX) sparked bullish action in the industry.'"
2/18/2014 12:27:06 PM - Hitting yet another new 52-week high today with a volume-driven gain. Prior mid-day reports cautioned members - "Reported earnings +5% on -5% sales revenues for the Sep '13 quarter. Prior quarterly comparisons have not been strong and steady above the +25% minimum guideline (C criteria). It survived but failed to impress since noted near its all-time high in the 4/11/11 mid-day report with caution. - 'Gapped up today for a new high after announcing plans to buy American Medical Systems Holdings Inc. (AMMD) in a near $3 Billion deal. It was already extended from a sound base as noted after 3/30/11 when it technically broke out of a long flat base while merger news involving Cephalon Inc (CEPH) after Valeant Pharmaceuticals Int'l (VRX) sparked bullish action in the industry.'"
11/13/2013 12:09:14 PM - Hitting yet another new 52-week high today while adding to its recent spurt of volume-driven gains. Prior mid-day reports cautioned members - "Reported earnings +5% on -5% sales revenues for the Sep '13 quarter. Prior quarterly comparisons have not been strong and steady above the +25% minimum guideline (C criteria). It survived but failed to impress since noted near its all-time high in the 4/11/11 mid-day report with caution. - 'Gapped up today for a new high after announcing plans to buy American Medical Systems Holdings Inc. (AMMD) in a near $3 Billion deal. It was already extended from a sound base as noted after 3/30/11 when it technically broke out of a long flat base while merger news involving Cephalon Inc (CEPH) after Valeant Pharmaceuticals Int'l (VRX) sparked bullish action in the industry.'"
11/8/2013 1:12:08 PM - Hitting a new 52-week high today while adding to its recent spurt of volume-driven gains. The 11/05/13 mid-day report cautioned members - "Reported earnings +5% on -5% sales revenues for the Sep '13 quarter. Prior quarterly comparisons have not been strong and steady above the +25% minimum guideline (C criteria). It survived but failed to impress since noted near its all-time high in the 4/11/11 mid-day report with caution. - 'Gapped up today for a new high after announcing plans to buy American Medical Systems Holdings Inc. (AMMD) in a near $3 Billion deal. It was already extended from a sound base as noted after 3/30/11 when it technically broke out of a long flat base while merger news involving Cephalon Inc (CEPH) after Valeant Pharmaceuticals Int'l (VRX) sparked bullish action in the industry.'"
11/6/2013 12:23:50 PM - Holding its ground today following a considerable gap up and volume-driven gain for a new 52-week high on the prior session. The 11/05/13 mid-day report cautioned members - "Reported earnings +5% on -5% sales revenues for the Sep '13 quarter. Prior quarterly comparisons have not been strong and steady above the +25% minimum guideline (C criteria). It survived but failed to impress since noted near its all-time high in the 4/11/11 mid-day report with caution. - 'Gapped up today for a new high after announcing plans to buy American Medical Systems Holdings Inc. (AMMD) in a near $3 Billion deal. It was already extended from a sound base as noted after 3/30/11 when it technically broke out of a long flat base while merger news involving Cephalon Inc (CEPH) after Valeant Pharmaceuticals Int'l (VRX) sparked bullish action in the industry.'"
11/5/2013 12:15:59 PM - Gapped up today for a considerable volume-driven gain and new 52-week high. Reported earnings +5% on -5% sales revenues for the Sep '13 quarter. Prior quarterly comparisons have not been strong and steady above the +25% minimum guideline (C criteria). It survived but failed to impress since noted near its all-time high in the 4/11/11 mid-day report with caution. - "Gapped up today for a new high after announcing plans to buy American Medical Systems Holdings Inc. (AMMD) in a near $3 Billion deal. It was already extended from a sound base as noted after 3/30/11 when it technically broke out of a long flat base while merger news involving Cephalon Inc (CEPH) after Valeant Pharmaceuticals Int'l (VRX) sparked bullish action in the industry."
10/4/2013 12:18:58 PM - Pulling back from its 52-week high hit this week after volume-driven gains. Reported earnings +12% on -2% sales revenues for the Jun '13 quarter and prior quarterly comparisons have not been strong and steady above the +25% minimum guideline (C criteria). It survived but failed to impress since noted near its all-time high in the 4/11/11 mid-day report with caution. - "Gapped up today for a new high after announcing plans to buy American Medical Systems Holdings Inc. (AMMD) in a near $3 Billion deal. It was already extended from a sound base as noted after 3/30/11 when it technically broke out of a long flat base while merger news involving Cephalon Inc (CEPH) after Valeant Pharmaceuticals Int'l (VRX) sparked bullish action in the industry."
9/13/2013 12:39:49 PM - Consolidating -2.9% off its 52-week high and it topped its 2011 high this week with a spurt of volume-driven gains. Reported earnings +12% on -2% sales revenues for the Jun '13 quarter and prior quarterly comparisons have not been strong and steady above the +25% minimum guideline (C criteria). It survived but failed to impress since noted near its all-time high in the 4/11/11 mid-day report with caution. - "Gapped up today for a new high after announcing plans to buy American Medical Systems Holdings Inc. (AMMD) in a near $3 Billion deal. It was already extended from a sound base as noted after 3/30/11 when it technically broke out of a long flat base while merger news involving Cephalon Inc (CEPH) after Valeant Pharmaceuticals Int'l (VRX) sparked bullish action in the industry."
6/27/2013 12:30:55 PM - Consolidating -6.1% off its 52-week high. Briefly topped its 2012 high on 6/17/13 after wedging higher in recent weeks with gains lacking great volume conviction. Reported earnings +25% on +3% sales revenues for the Mar '13 quarter. The 4 prior quarterly comparisons had earnings below the +25% guideline (C criteria. It survived but failed to impress since noted near its all-time high in the 4/11/11 mid-day report with caution. - "Gapped up today for a new high after announcing plans to buy American Medical Systems Holdings Inc. (AMMD) in a near $3 Billion deal. It was already extended from a sound base as noted after 3/30/11 when it technically broke out of a long flat base while merger news involving Cephalon Inc (CEPH) after Valeant Pharmaceuticals Int'l (VRX) sparked bullish action in the industry."
5/8/2013 12:24:14 PM - Perched at its 52-week high and within striking distance of its 2012 high after wedging higher in recent weeks with gains lacking great volume conviction. Reported earnings +25% on +3% sales revenues for the Mar '13 quarter. The 4 prior quarterly comparisons had earnings below the +25% guideline (C criteria. It survived but failed to impress since last noted near its all-time high in the 4/11/11 mid-day report with caution. - "Gapped up today for a new high after announcing plans to buy American Medical Systems Holdings Inc. (AMMD) in a near $3 Billion deal. It was already extended from a sound base as noted after 3/30/11 when it technically broke out of a long flat base while merger news involving Cephalon Inc (CEPH) after Valeant Pharmaceuticals Int'l (VRX) sparked bullish action in the industry."
4/11/2011 11:57:18 AM - Gapped up today for a new high after announcing plans to buy American Medical Systems Holdings Inc. (AMMD) in a near $3 Billion deal. It was already extended from a sound base as noted after 3/30/11 when it technically broke out of a long flat base while merger news involving Cephalon Inc (CEPH) after Valeant Pharmaceuticals Int'l (VRX) sparked bullish action in the industry. Recent quarterly comparisons for Sept and Dec '10 showed better sales and earnings increases versus the year earlier, but prior quarterly comparisons and annual earnings (A criteria) growth have not been strong and steady enough to meet the investment system guidelines. After a long hiatus, it was noted in the 12/30/10 mid-day report - "Long-ago it was a Featured Stock with favorable characteristics, and it was last noted in the mid-day report on 1/09/06."
4/8/2011 12:17:47 PM - Wedging higher after getting extended from its prior base. On 3/30/11 it technically broke out of a long flat base while merger news involving Cephalon Inc (CEPH) after Valeant Pharmaceuticals Int'l (VRX) sparked bullish action in the industry. Recent quarterly comparisons for Sept and Dec '10 showed better sales and earnings increases versus the year earlier, but prior quarterly comparisons and annual earnings (A criteria) growth have not been strong and steady enough to meet the investment system guidelines. After a long hiatus, it was noted in the 12/30/10 mid-day report - "Long-ago it was a Featured Stock with favorable characteristics, and it was last noted in the mid-day report on 1/09/06."
4/6/2011 12:43:56 PM - Extended from its prior base after a spurt of volume driven gains for new 52-week highs. On 3/30/11 it technically broke out of a long flat base while merger news involving Cephalon Inc (CEPH) after Valeant Pharmaceuticals Int'l (VRX) sparked bullish action in the industry. Recent quarterly comparisons for Sept and Dec '10 showed better sales and earnings increases versus the year earlier, but prior quarterly comparisons and annual earnings (A criteria) growth have not been strong and steady enough to meet the investment system guidelines. After a long hiatus, it was noted in the 12/30/10 mid-day report - "Long-ago it was a Featured Stock with favorable characteristics, and it was last noted in the mid-day report on 1/09/06."
3/31/2011 12:18:01 PM - Gapped up and rallied for a considerable gain with above average volume for a new 52-week high on the prior session, breaking out of a long flat base while merger news involving Cephalon Inc (CEPH) after Valeant Pharmaceuticals Int'l (VRX) sparked bullish action in the industry. Recent quarterly comparisons for Sept and Dec '10 showed better sales and earnings increases versus the year earlier, but prior quarterly comparisons and annual earnings (A criteria) growth have not been strong and steady enough to meet the investment system guidelines. After a long hiatus, it was noted in the 12/30/10 mid-day report - "Long-ago it was a Featured Stock with favorable characteristics, and it was last noted in the mid-day report on 1/09/06."
12/30/2010 12:42:59 PM - Gapped up today, rising back above its 50 DMA line while building on a 10 week flat base. Recent quarter ended September 30, 2010 showed better sales and earnings increases versus the year earlier, but prior quarterly comparisons and annual earnings (A criteria) growth have not been strong and steady enough to meet the investment system guidelines. Long-ago it was a Featured Stock with favorable characteristics, and it was last noted in the mid-day report on 1/09/06.
1/9/2006 12:38:42 PM - "C" now below guidelines. Featured in a CANSLIM.net Special Report to last March. Up over 117% since.
12/27/2005 12:42:46 PM - "C" now below guidelines. Featured in a CANSLIM.net Special Report to last March. Up over 117% since.
12/1/2005 12:49:19 PM - Base questionable. Featured in a CANSLIM.net Special Report to paying subscribers last March. Up over 117% since.
11/30/2005 12:43:34 PM - Base questionable. Featured in a CANSLIM.net Special Report to paying subscribers last March. Up over 117% since.
2/27/2004 1:00:00 PM - B- Featured in a CANSLIM.net Special Report to paying subscribers last March. Up over 117% since.